Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 27, 2024Open Access

Expanded tumor-associated polymorphonuclear Myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity

View Full Paper
Ask AI
Bookmark
Share

Authors

SAStephen M. AnsellVBVaishali BhardwajZYZhi-Zhang Yang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ansell et al. (2024) studied this question.

synapsesocial.com/papers/68e72303b6db64358769c970https://doi.org/10.21203/rs.3.rs-4144316/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1LOX1 expression identifies a population of polymorphonuclear myeloid-derived suppressor cells that are highly enriched in bone marrow samples of treatment-Naïve and BTKi-Relapsed/Refractory WM patients and show constitutive activation of BTK2025
  2. 2Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma2014 · 111 citations
  3. 3The effects of bruton tyrosine kinase inhibitors on the waldenstrom macroglobulinemia microenvironment2025
  4. 4Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 1: Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, risk stratification, and clinical problems.2024 · 11 citations
  5. 5Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy2024